- Home
- ERAS vs DMRC Comparison
ERAS vs DMRC Comparison
Compare ERAS & DMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- DMRC
- Stock Information
- Founded
- ERAS 2018
- DMRC 2008
- Country
- ERAS United States
- DMRC United States
- Employees
- ERAS N/A
- DMRC N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- DMRC EDP Services
- Sector
- ERAS Health Care
- DMRC Technology
- Exchange
- ERAS Nasdaq
- DMRC Nasdaq
- Market Cap
- ERAS 348.4M
- DMRC 290.7M
- IPO Year
- ERAS 2021
- DMRC N/A
- Fundamental
- Price
- ERAS $1.39
- DMRC $13.03
- Analyst Decision
- ERAS Strong Buy
- DMRC Strong Buy
- Analyst Count
- ERAS 6
- DMRC 1
- Target Price
- ERAS $4.83
- DMRC $30.00
- AVG Volume (30 Days)
- ERAS 1.5M
- DMRC 204.0K
- Earning Date
- ERAS 05-13-2025
- DMRC 05-05-2025
- Dividend Yield
- ERAS N/A
- DMRC N/A
- EPS Growth
- ERAS N/A
- DMRC N/A
- EPS
- ERAS N/A
- DMRC N/A
- Revenue
- ERAS N/A
- DMRC $37,848,000.00
- Revenue This Year
- ERAS N/A
- DMRC N/A
- Revenue Next Year
- ERAS N/A
- DMRC $11.24
- P/E Ratio
- ERAS N/A
- DMRC N/A
- Revenue Growth
- ERAS N/A
- DMRC 2.44
- 52 Week Low
- ERAS $1.01
- DMRC $10.44
- 52 Week High
- ERAS $3.45
- DMRC $48.32
- Technical
- Relative Strength Index (RSI)
- ERAS 54.43
- DMRC 48.60
- Support Level
- ERAS $1.06
- DMRC $12.64
- Resistance Level
- ERAS $1.47
- DMRC $13.29
- Average True Range (ATR)
- ERAS 0.14
- DMRC 0.50
- MACD
- ERAS 0.02
- DMRC 0.05
- Stochastic Oscillator
- ERAS 70.65
- DMRC 56.65
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About DMRC Digimarc Corporation
Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.